© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
June 27, 2017
Patient and treatment heterogeneity were characterized within a sample of nonadherent buprenorphine members; an improved understanding of these factors may optimize patient—treatment matching and intervention efforts.
January 23, 2014
Federal parity led to an increase in spending on substance use disorder treatment.
November 19, 2013
A large proportion of opioid analgesic treated chronic pain patients exhibited behaviors indicative of potentially problematic opioid use, which significantly affected healthcare costs.
July 01, 2004